Career Opportunities

Locations

New Haven, CT, USA

Size

1 - 10 employees

founded in

2017

Bioscience
Therapeutics

Cybrexa is a privately-held biotechnology company dedicated to developing next-generation tumor-targeted cancer therapies using its alphalex™ platform. The Company’s lead candidate, CBX-12, an alphalex™-exatecan conjugate, is expected to enter Phase I in 2021 in advanced solid tumors. Cybrexa also has other preclinical toxin conjugate programs as well as synthetic lethality programs. Cybrexa was founded by physician-scientists and has an experienced management team that has built numerous successful life sciences companies.

Inaccurate data? Flag it here.
Open jobs at Cybrexa